Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dite Venskus"'
Autor:
Guna Proboka, Evija Olmane, Dite Venskus, Māra Romanovska, Zanda Krastiņa, Kārlis Kupčs, Sergejs Isajevs, Romualds Erdmanis, Linda Brokāne, Jurijs Nazarovs, Pēteris Alberts
Publikováno v:
APMIS. 124:896-904
Oncolytic virotherapy is a recent addition to cancer treatment. Here, we describe positive treatment outcomes in three patients using Rigvir virotherapy. One of the patients is diagnosed with melanoma stage IV M1c, one with small cell lung cancer sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2efb9432aaa3d02b372100eff1d622db
https://doi.org/10.1111/apm.12576
https://doi.org/10.1111/apm.12576
Publikováno v:
European journal of pharmacology. 837
Oncolytic viruses are a fast-developing cancer treatment field. Numerous viruses have been tested in clinical trials and three are approved. The first, Rigvir, is an immunomodulator with anti-tumour effect for treatment of melanoma, local treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d28323397a17685a5fc07b18869a9853
https://pubmed.ncbi.nlm.nih.gov/30179611
https://pubmed.ncbi.nlm.nih.gov/30179611
Autor:
Pēteris Alberts, Aina Muceniece, Ieva Strēle, Guna Proboka, Dite Venskus, Björn Jonsson, Jurgis Auziņš, Simona Doniņa
Publikováno v:
Melanoma Research
An oncolytic, nonpathogenic ECHO-7 virus adapted for melanoma that has not been genetically modified (Rigvir) is approved and registered for virotherapy, an active and specific immunotherapy, in Latvia since 2004. The present retrospective study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d2ef411cd082961ad7a7a1be9a0482
https://pubmed.ncbi.nlm.nih.gov/26193376
https://pubmed.ncbi.nlm.nih.gov/26193376